Publication in Nature by IMPRiND partner Michel Goedert.

New insights into the cryo-EM structures of alpha-synuclein filaments isolated from MSA and DLB brain by IMPRiND partner Michel Goedert. Read the article.

RESEARCH HIGHLIGHT - The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies

IMPRIND Partner CNRS establishes a method where seeds from frozen brain tissues can seed the aggregation of pure alpha-synuclein.

Read more

Show more posts

This project receives funding from the Innovative Medicines Initiative 2 Joint Undertaking ( under grant agreement No 116060. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

This work is supported by the Swiss State Secretariat for Education‚ Research and Innovation (SERI) under contract number 17.00038.

The opinions expressed and arguments employed herein do not necessarily reflect the official views of these funding bodies.

© 2019 IMPRiND Project – created by SCIPROMPrivacy policy